708 event(s) found
3rd Pediatric Exercise Oncology Congress – PEOC meets FORTEe
Join leading clinicians, researchers, and stakeholders for two dynamic days focused on the future of exercise in pediatric oncology. Hear cutting-edge keynotes from David Mizrahi (Australia), Carmen Fiuza-Luces (Spain), Keri Schadler (USA), Martin Kaj Fridh (Denmark) and Precious Madzimbe (Zimbabwe) Present your latest findings through oral talks, rapid presentations, or interactive posters Connect with peers at our Congress Dinner and FORTE Science Evening Whether you’re an exercise professional, clinician, researcher, student, or patient advocate – PEOC × FORTE will inspire and equip you to integrate exercise into pediatric oncology care and research.
30th Acute Leukemia Forum
Celebrating its 30th year, the Acute Leukemia Forum (ALF) continues its tradition of being a premier event for hematology and oncology professionals. This milestone conference brings together leading experts to share groundbreaking research and clinical advances that shape the treatment and management of acute leukemia and myelodysplastic syndromes. As we look ahead to 2026, ALF will focus on addressing the evolving educational needs of those involved in the care of patients with these challenging malignancies.
AONN+ 2026 Midyear Conference
Join us live or virtually to gain practical insights and fresh perspectives across the cancer care continuum. AONN+ Midyear convenes oncology’s most influential nurse and patient navigators, social workers, and administrators to think boldly, share best practices, and drive meaningful change.
IMMUNOLOGY2026™
Annual conference of the American Association of Immunologists (AAI), featuring symposia, round-tables, poster sessions and more!
ESMO Summit Latin America 2026
The ESMO Summit Latin America 2025 is a two-day educational event with presentations focused on several key disease sites. Created for oncology professionals in Latin America by international and local key opinion leaders, the Summit will put into context the most significant treatment advances presented at the ESMO annual Congress. Summit Objectives: to provide the oncology community with a summary of the most significant treatment advances presented at the ESMO Congresses; to review the current standard of care for key malignancies from a local and international perspective; and to discuss the current controversies in the management of specific cancers Target Audience: Medical and clinical oncologists, pharmacists, nurses, students, fellows, residents, general practitioners in oncology and other oncology healthcare professionals.
AACR Annual Meeting 2026
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world. More information about the AACR Annual Meeting 2026 will be available online and in the Call for Abstracts in late August 2025.
AACR Oncology Industry Partnering Event: From Cancer Discoveries to Patients
This annual event provides a unique networking experience for attendees to learn from our industry partners who will highlight the oncology pipelines and platforms of leading pharmaceutical and biotechnology companies as well as emerging scientific themes across the biopharmaceutical industry. This oncology-focused event will once again feature thought-leaders who will share their innovation strategies for drug development and present analysts and investors new partnership and licensing opportunities to advance these concepts.
3er Workshop INFECTHEMA
In Spanish: "Estamos encantados de invitaros a la 3a edición del workshop de Infecciones en Hematología INFECTHEMA, que tendrá lugar en Valencia los próximos días 16 y 17 de abril en el edificio Veles e Vents."
3rd Pediatric Exercise Oncology Congress – PEOC meets FORTEe
Join leading clinicians, researchers, and stakeholders for two dynamic days focused on the future of exercise in pediatric oncology. Hear cutting-edge keynotes from David Mizrahi (Australia), Carmen Fiuza-Luces (Spain), Keri Schadler (USA), Martin Kaj Fridh (Denmark) and Precious Madzimbe (Zimbabwe) Present your latest findings through oral talks, rapid presentations, or interactive posters Connect with peers at our Congress Dinner and FORTE Science Evening Whether you’re an exercise professional, clinician, researcher, student, or patient advocate – PEOC × FORTE will inspire and equip you to integrate exercise into pediatric oncology care and research.
Texas Blood Cancer Conference
Blood Cancer United Blood Cancer Conferences are free education events for blood cancer patients, survivors, caregivers, family members and healthcare professionals to learn more about treatment options, emerging therapies, management of survivorship issues and Blood Cancer United resources.
AACR Annual Meeting 2026
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world. More information about the AACR Annual Meeting 2026 will be available online and in the Call for Abstracts in late August 2025.
ESMO Summit Latin America 2026
The ESMO Summit Latin America 2025 is a two-day educational event with presentations focused on several key disease sites. Created for oncology professionals in Latin America by international and local key opinion leaders, the Summit will put into context the most significant treatment advances presented at the ESMO annual Congress. Summit Objectives: to provide the oncology community with a summary of the most significant treatment advances presented at the ESMO Congresses; to review the current standard of care for key malignancies from a local and international perspective; and to discuss the current controversies in the management of specific cancers Target Audience: Medical and clinical oncologists, pharmacists, nurses, students, fellows, residents, general practitioners in oncology and other oncology healthcare professionals.
Texas Blood Cancer Conference
Blood Cancer United Blood Cancer Conferences are free education events for blood cancer patients, survivors, caregivers, family members and healthcare professionals to learn more about treatment options, emerging therapies, management of survivorship issues and Blood Cancer United resources.
APS 2026
APS 2026 organized by APS
BSH 66th Annual Scientific Meeting
The 66th Annual Scientific Meeting of the British Society for Haematology (BSH) features a thoughtful programme that reflects the breadth of modern haematology, from core practice to emerging science. It is designed to be relevant and engaging for haematologists, scientists, nurses, and professionals across all sub-specialities within the field. We very much hope you’ll join us in Liverpool for what promises to be an inspiring and enjoyable meeting, and look forward to welcoming you there in 2026.
World Indigenous Cancer Conference 2026
World Indigenous Cancer Conference 2026 organized by Hei Āhuru Mōwai Maori Cancer Leadership Aotearoa
Webinaire SFjRO - Avril 2026 : Radiothérapie des cancers ORL
In French: "Ne manquez pas le premier épisode de cette nouvelle saison des Webinaires SFjRO ! 🎓 Préparez-vous avec des cas cliniques pratiques à compléter avant le webinaire pour une mise en situation concrète : https://lnkd.in/epBcxhJe 👉 Radiothérapie des cancers ORL 🎙️ Animé par le Pr. Florence Huguet et le Dr. Cécile Evin de l’Hôpital Tenon - AP-HP, Assistance Publique - Hôpitaux de Paris 📅 Lundi 20 avril 2026 ⏰ 19h30 🖥️ En visio - lien de connexion diffusé le jour J Au programme : Mise au point théorique et pratique sur la prise en charge en radiothérapie des cancers ORL. Une occasion privilégiée d’actualiser nos connaissances et d’échanger autours de cette localisation complexe."
Oncostream webinar: Cancers de mauvais pronostic féminins : A quel moment faire un séquençage génomique, pour qui, pourquoi ?
In French: "PROGRAMME : 18:00 Introduction (Réseau FEM-NET et objectifs) Isabelle Ray-Coquard 18:05 Les différents types de séquençages (petit et moyen panels, séquençage complet) Sophie Cotteret 18:15 Constats de terrain par les associations de patientes Claude Coutier & Coralie Marjollet 18:30 Quels sont les apports réels d’un séquençage, à qui bénéficie-t-il ? Olivier Tredan & Claudia Lefeuvre-Plesse 18:40 PFMG 2025 : Objectifs, apports, difficultés et avenir Frédérique Nowak 18:55 Table ronde : Quel est le positionnement de FEM-NET et quelle organisation concrète pour mettre en place cet accès équitable au séquençage ? Thomas Bachelot, Sophie Cotteret, Claude Coutier, Véronique Dieras, Claudia Lefeuvre-Plesse, Coralie Marjollet & Olivier Tredan 19:20 Synthèse du positionnement de FEM-NET Thomas Bachelot"
PSCC Petit déjeuner de l'écosystème - Introducing MIPP: The Modelling, ImmunoProfiling and Pharmacology Platform for Translational Innovation
Don't miss the next Ecosystem Breakfast on the topic: Introducing MIPP: The Modelling, ImmunoProfiling and Pharmacology Platform for Translational Innovation. Featuring Anna Martirosyan, MIPP platform (Modelling, ImmunoProfiling and Pharmacology Platform), Hôpitaux Universitaires de Marseille
Innovations in Translational Models: Replacing In Vivo Models With Complex Cellular Systems
More information coming soon…
Lung Cancer Europe Conference 2026
The Lung Cancer Europe 2026 Conference will bring member organisations together in Vienna for three days of learning, connection, and shared priorities. Designed for Lung Cancer Europe members, the conference focuses on practical exchange, collaboration, and strengthening lung cancer advocacy across Europe.
11th Translational Research Conference: Myeloproliferative Neoplasms
ESH Translational Research Conferences focus on leading-edge basic, clinical and therapeutic research and future perspectives. The presentation of unpublished data is encouraged. Ample time is deliberately provided for in-depth scientific discussion and interaction. Registered participants further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in their field, including during small Meet the Expert sessions and Mentored Posters Walks. New insights into the molecular pathogenesis, classification, and management of patients with Myeloproliferative Neoplasms (MPN) have arisen at increasing pace during the past years. This International Conference brings together scientists and clinicians to present and discuss new data on the cellular and molecular biology of these disorders as well as their diagnosis and treatment.
Jeudi du PSCC #19 : In vivo CAR
We are pleased to welcome three outstanding speakers bringing complementary perspectives from research, industry and investment: · Silvia Menegatti, Head of R&D, CellAction / Institut Curie · Christopher Borges, Head of Non-Viral Gene Therapy and Genome Engineering, Sanofi · Sofia Arnal, AdBio partners Together, they will explore the opportunities and challenges shaping in vivo CAR approaches, from scientific innovation and translational development to industrial and investment perspectives.
Location-Specific T-cell Inhibitory Molecules (LoSTIMs) for targeted immunosuppression
Welcome to the Transdisciplinary Immunology Journal Club (TIJC) — your global hub for cutting-edge immunology, cross-disciplinary insights, and career development. TIJC unites physicians, researchers, and students worldwide to explore breakthroughs in immunology, oncology, autoimmunity, and translational medicine. Speaker: James Torchia (Dana-Farber Cancer Institute)